Why Wearables are no Gimmick in the Quest for Wellness
It is well understood that increased physical activity levels are linked with a reduced risk of certain illnesses, leading to improved healthy life expectancy. Wearable devices have also been championed as a way to not only help people track physical activity, but with the right incentives, increase overall activity levels in the short term.
Adult Congenital Heart Disease
The definition of congenital heart disease (CHD) is the persistence of any structural abnormality of the heart or great vessels that is present at birth. Those patients with CHD who achieve adulthood are considered to have adult congenital heart disease (ACHD). This is a very heterogenous group, consisting of multiple types of lesions and various stages of repair.
Cancer Mortality Patterns in Insured Lives
For life insurers, a major source of mortality risk mitigation is prudent underwriting at the time of application, which should ultimately reduce future claim costs. One way to refine the underwriting process is through measuring the impact of underwriting using insurance claims experience.
Seasonal Influenza and Mortality
Can big data from a bad flu season yield insights into all-cause mortality and help guide insurance risk assessment? RGA and Blue Dot partner to explore the global spread of infectious disease and arrive at fascinating insights.
Risk Assessment of the Kidney Transplant Recipient
For underwriters, correctly assessing the potential mortality and morbidity risk of applicants who are past renal transplant recipients involves understanding a broad range of issues related to kidney disease, current transplantation science, long term graft success, post-transplant survival predictors, and the common causes of death in kidney transplant recipients.
Look Beyond the Medical Treatments (SCORviews)
If mortality improvement is a three-legged stool, improved treatment of disease is only one leg; the other two legs are prevention and early detection
US Life Expectancy Drops Again Amid Opioid Crisis
First time in more than 50 years that it fell twice in a row; deaths linked to synthetic opioids doubled from 2015 to 2016
SCORviews October 2017 Issue
Articles featured in the October 2017 issue of SCORviews include:
- Modeling Policyholder Behavior
- Innovations in Life Insurance
- SCOR Mortality Insight
Drug Abuse Mortality in the Insured Population
Population data show that drug-related mortality rates have more than doubled since the beginning of the century. This statistic is troubling enough as it is, but it hides the fact that almost all the increase is due to opioids, which account for just over half of the deaths.
Opioid Epidemic – How Did We Get Here?
This paper seeks to understand the unique set of circumstances that led to the dramatic rise in opioid prescriptions over the last few decades, and provide a brief overview of the resultant morbidity and mortality for the insured population.